Clinical trials
Phase 1/2 Liver Neoplasms trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
50 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 4 |
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 2 |
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 3 |
| 2008 | 1 |
| 2009 | 1 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 2 |
| 2021 | 1 |
| 2022 | 8 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 26 |
| Terminated | 7 |
| Recruiting | 6 |
| Withdrawn | 5 |
| Active, not recruiting | 3 |
| Unknown status | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 3 |
| National Cancer Institute (NCI) | 3 |
| Alliance for Clinical Trials in Oncology | 2 |
| Eureka Therapeutics Inc. | 2 |
| Jonsson Comprehensive Cancer Center | 2 |
| University of Rochester | 2 |
| 7 Hills Pharma, LLC | 1 |
| Arbutus Biopharma Corporation | 1 |
| AstraZeneca | 1 |
| Basilea Pharmaceutica | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Liver Neoplasms | 50 |
| Carcinoma, Hepatocellular | 30 |
| Colorectal Neoplasms | 9 |
| Stomach Neoplasms | 9 |
| Breast Neoplasms | 8 |
| Neoplasm Metastasis | 8 |
| Pancreatic Neoplasms | 8 |
| Colonic Neoplasms | 7 |
| Neoplasms | 7 |
| Bile Duct Neoplasms | 5 |
Trials
Showing 1 to 25 of 50. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.